Gene Therapy of Mpl Deficiency: Challenging Balance Between Leukemia and Pancytopenia
Open Access
- 1 February 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (2) , 343-352
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Increased Differentiation of Dermal Mast Cells in Mice Lacking the Mpl GeneStem Cells and Development, 2009
- Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical ModelsMolecular Therapy, 2009
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJournal of Clinical Investigation, 2009
- Genomic and Functional Assays Demonstrate Reduced Gammaretroviral Vector Genotoxicity Associated With Use of the cHS4 Chromatin InsulatorMolecular Therapy, 2009
- Incomplete restoration of Mpl expression in the mpl−/− mouse produces partial correction of the stem cell–repopulating defect and paradoxical thrombocytosisBlood, 2009
- Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16Leukemia, 2008
- Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clonesBlood, 2007
- Role of Thrombopoietin in Mast Cell DifferentiationAnnals of the New York Academy of Sciences, 2007
- The Genetic Engineering of Hematopoietic Stem Cells: the Rise of Lentiviral Vectors, the Conundrum of the LTR, and the Promise of Lineage-restricted VectorsMolecular Therapy, 2007
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006